» Articles » PMID: 26704725

Trajectory of Body Shape Across the Lifespan and Cancer Risk

Overview
Journal Int J Cancer
Specialty Oncology
Date 2015 Dec 26
PMID 26704725
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

The influence of adiposity over life course on cancer risk remains poorly understood. We assessed trajectories of body shape from age 5 up to 60 using a group-based modeling approach among 73,581 women from the Nurses' Health Study and 32,632 men from the Health Professionals Follow-up Study. After a median of approximately 10 years of follow-up, we compared incidence of total and obesity-related cancers (cancers of the esophagus [adenocarcinoma only], colorectum, pancreas, breast [after menopause], endometrium, ovaries, prostate [advanced only], kidney, liver and gallbladder) between these trajectories. We identified five distinct trajectories of body shape: lean-stable, lean-moderate increase, lean-marked increase, medium-stable, and heavy-stable/increase. Compared with women in the lean-stable trajectory, those in the lean-marked increase and heavy-stable/increase trajectories had a higher cancer risk in the colorectum, esophagus, pancreas, kidney, and endometrium (relative risk [RR] ranged from 1.22 to 2.56). Early life adiposity was inversely while late life adiposity was positively associated with postmenopausal breast cancer risk. In men, increased body fatness at any life period was associated with a higher risk of esophageal adenocarcinoma and colorectal cancer (RR ranged from 1.23 to 3.01), and the heavy-stable/increase trajectory was associated with a higher risk of pancreatic cancer, but lower risk of advanced prostate cancer. The trajectory-cancer associations were generally stronger for non-smokers and women who did not use menopausal hormone therapy. In conclusion, trajectories of body shape throughout life were related to cancer risk with varied patterns by sex and organ, indicating a role for lifetime adiposity in carcinogenesis.

Citing Articles

From Surviving to Thriving: Key Considerations for Weight Control Across Diverse Cancer Survivorship Populations.

Brown J, Allicock M, Valle C, Agurs-Collins T Obes Sci Pract. 2024; 10(6):e70027.

PMID: 39619051 PMC: 11605365. DOI: 10.1002/osp4.70027.


Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study.

Cariolou M, Christakoudi S, Gunter M, Key T, Perez-Cornago A, Travis R JNCI Cancer Spectr. 2024; 8(5).

PMID: 39180334 PMC: 11410200. DOI: 10.1093/jncics/pkae070.


A longitudinal investigation of risk perceptions and adaptation behavior in the US Gulf Coast.

Wong-Parodi G, Relihan D, Garfin D PNAS Nexus. 2024; 3(4):pgae099.

PMID: 38595802 PMC: 11003376. DOI: 10.1093/pnasnexus/pgae099.


Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study.

Stoyten M, Knutsen T, Stikbakke E, Agledahl I, Wilsgaard T, Eggen A Acta Oncol. 2024; 63:154-163.

PMID: 38591351 PMC: 11332472. DOI: 10.2340/1651-226X.2024.32953.


Taking a Weight History - Using Mnemonics to Learn a Missing Skill in Medical Education.

Kushner R MedEdPublish (2016). 2024; 6:215.

PMID: 38406435 PMC: 10885228. DOI: 10.15694/mep.2017.000215.


References
1.
Bassett J, Severi G, Baglietto L, MacInnis R, Hoang H, Hopper J . Weight change and prostate cancer incidence and mortality. Int J Cancer. 2012; 131(7):1711-9. DOI: 10.1002/ijc.27414. View

2.
Must A, Willett W, Dietz W . Remote recall of childhood height, weight, and body build by elderly subjects. Am J Epidemiol. 1993; 138(1):56-64. DOI: 10.1093/oxfordjournals.aje.a116777. View

3.
Hilakivi-Clarke L, Forsen T, Eriksson J, Luoto R, Tuomilehto J, Osmond C . Tallness and overweight during childhood have opposing effects on breast cancer risk. Br J Cancer. 2001; 85(11):1680-4. PMC: 2363976. DOI: 10.1054/bjoc.2001.2109. View

4.
Huang Z, Hankinson S, Colditz G, Stampfer M, Hunter D, Manson J . Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997; 278(17):1407-11. View

5.
Levi Z, Kark J, Barchana M, Liphshitz I, Zavdy O, Tzur D . Measured body mass index in adolescence and the incidence of colorectal cancer in a cohort of 1.1 million males. Cancer Epidemiol Biomarkers Prev. 2011; 20(12):2524-31. DOI: 10.1158/1055-9965.EPI-11-0531. View